Biomedical Research

Research Article - Biomedical Research (2018) Volume 29, Issue 5

Effects of Tongluotangtai recipe on serum pain substances 5-HT, B-EP, histamine and bradykinin in rats with painful diabetic peripheral neuropathy model of streptozotocin (STZ)

Li Haizhen1,2, Zheng Guanlin3, Zhuang Xianghua4, Wang Cailing4 and Chen Shihong1*

1Department of Endocrinology, the Second Hospital of Shandong University, PR China

2Department of Endocrinology, People's Hospital of Dongying District, Shandong, PR China

3Department of Endocrinology, Taishan Shandong Vocational Nursing College, the Second Hospital of Shandong University, PR China

*Corresponding Author:
Chen Shihong
Department of Endocrinology
The second hospital of Shandong University, PR China

Accepted date: November 29, 2017

DOI: 10.4066/biomedicalresearch.29-17-3167

Visit for more related articles at Biomedical Research

Abstract

Objective: To investigate the effect of Tongluotangtai decoction on 5-HT, β-EP, histamine and bradykinin in serum of STZ rats with pain-related diabetic neuropathy.

Methods: The rat model of diabetic peripheral neuropathy was made by intraperitoneal injection of STZ. The rats were divided into control group, model group, Tongluo sugar group and phenytoin. The rats were administrated with saline, Tongluo sugar Thai or phenytoin sodium daily, and the levels of 5- HT, β-EP, histamine and bradykinin in the serum of each group were measured after 3 w, 5 w and 9 w.

Results: After 3 w, 5 w and 9 w of drug intervention, the levels of 5-HT, histamine and bradykinin in the model group were significantly higher than those in the control group (P<0.05) and the level of β-EP was significantly reduced. Compared with the model group, the contents of histamine and bradykinin in Tongtao Tangtai group and phenytoin group were significantly decreased and the level of β-EP was significantly reduced. Compared with the rats in the phenytoin group, the contents of histamine and bradykinin in Tongtao Suantai group and phenytoin group were significantly decreased and the level of β-EP was significantly reduced.

Conclusion: Tongtao Tangtai decoction can significantly reduce the level of 5-HT, histamine and bradykinin in STZ-induced diabetic neuropathy model rats, increase the content of β-EP and exert a significant anti-pain effect.

Keywords

Diabetic peripheral neuropathy model, Tongluo sugar Thai side, 5-HT, β-EP, Histamine, Bradykinin

Introduction

Diabetes Mellitus (MD) is an important disease influencing people’s health. With the improvement of people’s diet, its incidence rate and mortality rate increase. It is predicted incidence rate over the world in 2013 will excess 333 million, only secondary to cardiovascular diseases and tumor, the third non-infectious diseases [1,2]. The complications of diabetes are multiple, of which, Diabetic Peripheral Neuropathy (DPN) is one of the most common complications, the main factor causing disability and death of diabetes patients. According to the clinical studies, the symptom manifestation of DPN is pain. The clinical manifestations are spontaneous burning or lightning -like pain in lower abdomen, end of lower limbs, and lateral part of thigh. During onset, it will cause great pain, it is difficult to tolerate [3,4]. Therefore, finding DNP effective method can not only relieve pain of patients, also has an important significance in reducing disability and death rate induced by diabetes. Chinese herbs are the unique treasure in China. There are many reports show that Tongluotangtai Polypharmaceutical formula can relieve secretion of DNP rat inflammatory cellular factors, promote recovery of nerve function and play the prevention and treatment of DNP [5]. 5- HT, β-EP, histamine and bradykinin are the important pain indexes. Study on level changes of substances above has significance on DNP pain relieving and degree. Therefore, this study select STZ to produce peripheral neurological lesion model of rats pain diabetes and explore the influences of Tongluotangtai poly-pharmaceutical formula on Tongluotangtai poly-pharmaceutical formula of rats serum pain substance model, which provide experience for clinical study. Now results reported as followed.

Materials and Methods

Experimental animals

Ethical approval was given by the medical ethics committee of the second hospital of Shandong University with the following reference number: 2016008,Healthy adult SD 180 rats with the weight of 180 to 220 g for 2 to 4 months bought from Beijing vital river experimental animals technology Co., Ltd. Qualified number: scxk (jing) 2016-0001. All animals fed in the criteria condition. The specific conditions include 12 h light or dark circulation under 20 to 23°C. The relative humidity is 50%. All procedures followed “Experimental nursing and use guidance” of NIH.

Reagent and instruments

Tongluotangtai poly-pharmaceutical formula was made by preparation room of affiliated hospital in Chengdu university of Chinese medicine. The production batch number was 20071027. The main ingredients included berberine, Rhizoma Corydalpis, Scrophularia ningpoensis, Cortex Lycii, Silkworm excrement, leech, White mustard seed, borneol and so on. This drug was made by concentration and extraction of herbs above. When we used it, adding normal saline to the needed concentration. The effects of 1 ml extract were equal to 10 g crude herbs.

STZ bought from America Sigma Company; phenyton sodium bought from Shanxi Yunpeng pharmaceutical Co., Ltd. SFDA approval number was H14020776. ELISA bought from Shenzhen Dakewe Biotech Co., Ltd.

Instrument: ELISA bought from ThermoFisher Scientific (China) Co., Ltd. Type number was NanoDrop1000; lowtemperature high-speed centrifugal machine bought from ThermoFisher Scientific (China) Co., Ltd. Micropipettor bought from Eppendorf Co., Ltd (China); glucose meter bought from America Johnson company.

Experimental methods and grouping

180 rats were selected 30 cases according to weight differences after one-week normal feeding. These 30 rats were divided into three groups, each 10, they were three-week group, five-week group and nine-week group. 30 rats above were not given diabetes modeling. Other 150 rats were given diabetes modeling. The modeling method reported as the following. There were positive 90 rats with pain sensitivity of diabetes by computer random selection, they were divided into model three-week group, five-week group, nine-week group, Tongluotangtai three-week group, five-week group, nine-week group, phenytoin sodium three-week group, five-week group, nine-week group, each 10 rats.

Modeling method

Giving fating and water deprivation before modeling. Then we injected 2% STZ solution by abdominal cavity (using 0.1 mol/l citric acid buffer to place, PH 4.2). Injection dosage was set as 53 mg/kg. After 72 h, we measured blood glucose of tail in rats. Rats with blood glucose of 16.7 mmol/l were the successful modeling rats. The control group was given 0.1 mol/l citric acid buffer of the same volume.

The measurement methods of diabetes pain sensitivity: after 21 d of diabetes modeling, the rats were given mechanical withdrawal reflection test. The specific test included placing metal mesh on a plexiglass case (22 × 12 × 22 cm). The modeling rats were placed in case for 15 min. Then we used 10 g nylon wire to mechanically stimulate middle part of feet in hind leg of rats for 4 s continuously. Positive reaction was the feet lift or licking feet, no reaction meant negative. The stimulation of rats was from weak to strong, each intensity for 10 times. The median interval was about 3 s. The intensity of five foot withdrawal was PWMT. Rats who not reached to pain sensitivity threshold value had been excluded.

Administration methods

After 21 d of STZ modeling, rats in this study were given intragastric administration. Concentration and collocation method: Tongluotangtai formula was 10 mg/kg/d (normal saline collocation); phyenytoin sodium was 10 mg/kg/d (phyenytoin sodium was crushed with warm water into suspension); the blank control group and model group were given normal saline with the same volume. They were given once administration to three-week, five-week and nine-week.

Observation indexes

First, blood glucose of tails in rats were measured before modeling, 3 w, 5 w and 9 w after modeling; second, after 3 w, 5 w and 9 w after administration intervention, rats were given anesthesia, then we collected blood in aorta abdominalis, centrifugation serum. Using ELISA to measure the level of pain-relief substances such as 5-HT, β-EP, histamine and bradykinin in serum.

Data management

We used SPSS 17.0 software to study and deal with all data in this study. Measurement data used (͞x ± s) and t-test. Enumeration data used n% and χ2 test. P<0.05, there were statistical differences.

Results

Blood glucose conditions of tails in rats after 72 h of modeling in various groups

After giving STZ modeling of rats in various groups, blood glucose concentration of rats in model group, Tongluotangtai formula group and phenytoin sodium group higher than the control group obviously (P<0.05), there were no obvious differences in blood glucose of rats between model group, Tongluotangtai formula group and phenytoin sodium group (P>0.05), it can applied to the following test (Table 1, ͞x ± s).

Group Number (n) Blood glucose (mmol/l)
The control group 10 7.15 ± 1.45
The model group 10 21.67 ± 3.27a
Tongluotangtai formula group 10 22.04 ± 4.02a
phenytoin sodium group 10 21.94 ± 3.27a

Table 1. Blood glucose conditions of tails in rats after 72 h of modeling in various group (͞x ± s).

Comparison in serum pain substances level of rats in various groups after 3 w of drug intervention

Compared with the control group, 5-HT, histamine and bradykinin of rats in the model group increased obviously after 3 w of drug intervention (P<0.05), β-EP decreased obviously (P<0.05); compared with rats in the model group, 5-HT, histamine and bradykinin of rats in Tongluotangtai formula group and phenytoin sodium group decreased obviously (P<0.05), β-EP increased obviously (P<0.05); and compared with rats in phenytoin sodium group, 5-HT, histamine and bradykinin of rats in Tongluotangtai formula group and phenytoin sodium group decreased obviously (P<0.05), β-EP increased obviously (P<0.05, Table 2).

Group Number (n) 5-HT β-EP Histamine Bradykinin
The control group 10 21.84 ± 5.01 51.35 ± 10.64 23.57 ± 5.94 5.87 ± 1.04
The model group 10 59.46 ± 10.27a 15.07 ± 3.40 a 82.04 ± 18.43a 18.24 ± 3.26a
Tongluotangtai formula group 10 46.57 ± 8.21abc 23.46 ± 6.17abc 57.46 ± 8.26abc 11.55 ± 2.71abc
phenytoin sodium group 10 49.43 ± 9.07ab 19.04 ± 5.37ab 64.18 ± 11.74ab 14.25 ± 3.14ab

Table 2. Comparison in serum pain substances level of rats in various groups after 3 w of drug intervention (ng/l, ͞x ± s).

Comparison in serum pain substances level of rats in various groups after 5 w of drug intervention

Compared with the control group, 5-HT, histamine and bradykinin of rats in the model group increased obviously after 5 w of drug intervention (P<0.05), β-EP decreased obviously (P<0.05); compared with rats in the model group, 5-HT, histamine and bradykinin of rats in Tongluotangtai formula group and phenytoin sodium group decreased obviously (P<0.05), β-EP increased obviously (P<0.05); and compared with rats in phenytoin sodium group, 5-HT, histamine and bradykinin of rats in Tongluotangtai formula group and phenytoin sodium group decreased obviously (P<0.05), β-EP increased obviously (P<0.05, Table 3).

Group Number (n) 5-HT β-EP Histamine Bradykinin
The control group 10 22.65 ± 7.13 49.55 ± 13.57 20.74 ± 5.71 6.84 ± 1.67
The model group 10 93.46 ± 18.46a 15.34 ± 3.46 a 127.59 ± 25.47a 27.42 ± 5.74a
Tongluotangtai formula group 10 45.18 ± 7.98abc 26.97 ± 5.74abc 56.44 ± 6.72abc 11.55 ± 2.71abc
Phenytoin sodium group 10 52.76 ± 9.47ab 21.42 ± 4.47ab 62.58 ± 8.29ab 14.25 ± 3.14ab

Table 3. Comparison in serum pain substances level of rats in various groups after 5 w of drug intervention (ng/l, ͞x ± s).

Comparison in serum pain substances level of rats in various groups after 9 w of drug intervention

The results of nine-week intervention were similar to the fiveweek intervention. Compared with the control group, 5-HT, histamine and bradykinin of rats in the model group increased obviously (P<0.05), β-EP decreased obviously (P<0.05); compared with rats in the model group, 5-HT, histamine and bradykinin of rats in Tongluotangtai formula group and phenytoin sodium group decreased obviously (P<0.05), β-EP increased obviously (P<0.05); and compared with rats in phenytoin sodium group, 5-HT, histamine and bradykinin of rats in Tongluotangtai formula group and phenytoin sodium group decreased obviously (P<0.05), β-EP increased obviously (P<0.05, Table 4).

Group Number (n) 5-HT β-EP Histamine Bradykinin
The control group 10 25.94 ± 5.13 52.87 ± 15.74 21.05 ± 3.88 6.21 ± 0.79
The model group 10 115.74 ± 20.46a 12.95 ± 2.55a 138.46 ± 26.74a 27.49 ± 4.19a
Tongluotangtai formula group 10 32.97 ± 5.71abc 27.21 ± 3.84abc 43.89 ± 5.74abc 12.55 ± 2.71abc
Phenytoin sodium group 10 41.08 ± 6.89ab 21.77 ± 2.13ab 54.94 ± 6.49ab 15.84 ± 3.74ab

Table 4. Comparison in serum pain substances level of rats in various groups after 9 w of drug intervention (ng/l, ͞x ± s).

Discussion

At present, treatment for DNP in clinic only can be relieved not be treated completely. The sharp pain caused by DNP recurrence onset will bring great pain to patients. Pain caused by DNP have characteristics of limb onset, symmetrical onset, more severe at night and so on, it accompanies with feeling loss [6,7]. Therefore, prompt DNP pain relief has an important significance in treatment of diabetes patients. In TCM theory, the main reasons of pain is Qi and blood stasis, thus causing qi stagnation and pain; chronic pain will cause qi and blood consumption, internal injury in liver, liver qi stagnation, thus leading to qi stagnation and pain [8,9].

Jing-yue complete work pain in the chest and abdomen has recorded that pain can be caused by deficiency or excess. Patients with long-time pain most belong to deficiency, patients with acute pain most belong to excess. The main ingredients of tongluotangtai extract include berberine, Rhizoma Corydalpis, Scrophularia ningpoensis, Cortex Lycii, Silkworm excrement, leech, White mustard seed, borneol and so on, of which, berberine has significant effects of antiinflammation, resolving heatness, lowering blood lipid and anti-oxidant, can inhibit inflammation accumulation of diabetes patients in vivo. Rhizoma Corydalpis has good effects of easing pain and local anesthesia. Herbal truth-seeking has recorded that whatever qi and blood, patients who have stagnation, taking Rhizoma Corydalpis will be benefit for smoothing qi because of its warm nature, so the qi and blood can circulate smoothly; Scrophularia ningpoensis can clear away heatness, cool blood, nourish yin, reduce fire, relieve toxin and remove stagnation; Cortex Lycii has effects of cooling blood, removing steam-heat, clearing away lung and reducing fire; silkworm excrement and leech can resolve stasis to prevent and treat cardiovascular diseases; White mustard seed can warm lung, remove phlegm and regulate qi. Bingpian can remove stagnation, smooth meridian and stop pain. Combination of these herbs can significantly relieve pain cause y qi and blood stasis of DPN patients [10,11]. Clinical studies show that Tongluotangtai formula can effectively relieve clinical symptoms of DNP and improve conduction of nerve through regulation of whole body, it has good effects on the prevention and treatment of DNP [10]. Reports of Zhang also show that Tongluotangtai formula can significantly inhibit JNK signal pathway of rats with peripheral neural lesions of diabetes, has anti-inflammation effect, thus protecting nerve obviously [12,13]. The reports about the pain relief of Tongluotangtai formula on DNP are rare. Therefore, this study explores the influences of Tongluotangtai formula on 5-HT, β- EP, histamine and bradykinin in serum of rats in DPN model caused by STZ.

β-EP is a kind of important endogenous opioid peptide, can play the sedation and analgesia function combined with opioid receptor, especially in inflammation control [14,15]. 5-HT as a kind of monoamine neurotransmitter, can regulate and control horizontal downward damaging stimulation of spinal cord, play the function of lowering the pain sensitivity of body [16,17]. Bradykinin can produce the function similar to morphine combined with morphine receptor in brain, it has been verified in many reports that have significant inflammation pain promoting function, but its effects and mechanism are still unclear [15]. Histamine mainly exists in neuron and mastocyte of brain, is aminergic neurotransmitter, it participates in multiple physiological function of central pivot and peripheral part [18,19]. There are reports showing that histamine level can significantly promote pain threshold of body. The recent studies has found that phenytoin sodium has significant analgesia effect, can regulate release of multiple neurotransmitter of brain to avoid over excitation of neuron and inhibit abnormal discharge of feeling neuron through multiple pathways to relieve pain, as well as promote the tolerance of volume on pain through anti-anxiety and sedation. It has been used as positive drug to inhibit pain in many studies [20]. Results of this study show that we measure 5-HT, β-EP, histamine and bradykinin in serum of rats in the third, fifth and ninth week after administration of Tongluotnagtai formula and phenytoin sodium for DNP rats. The results show that 5-HT, histamine and bradykinin in the model group increased obviously, while β-EP level decreased obviously; histamine and bradykinin in serum of rats in Tongluotnagtai formula group and phenytoin sodium group decreased obviously, while β-EP level increased obviously; furthermore, Tongluotnagtai formula has more significant effects.

In conclusion, Tongluotnagtai formula can significantly lower 5-HT, β-EP, histamine and bradykinin in serum of rats in painful DPN model caused by STZ, increase β-EP level, thus play significant anti-pain function.

References